Mallinckrodt plc Ordinary Share (MNK) Trades at 52-Week Low


The company is so far trading down by 5.03%% since yesterday’s close of 32.42. Shares are trading at $30.79 which is significantly lower than the 50 day moving average which is $35.01 and quite a bit below the 200 day moving average of $40.89. The 50 day moving average was down $-4.22 whereas the 200 day moving average was down $-10.10 or -24.70%.

Short traders are feeling a little more bearish of late looking at the uptick in short interest. The firm saw a rise in short interest of 0.02% as of September 29, 2017 from the last reporting period. Short interest increased 4,467 over that timeframe. The days to cover increased to 11.0 and the short interest percentage is 0.20% as of September 29.

Mallinckrodt public limited company, launched on January 9, 2013, develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs. The Business’s segments include Specialty Brands and Specialty Generics. The Specialty Brands segment produces and markets branded pharmaceutical products and therapies. The Specialty Generics segment produces and markets specialty generic pharmaceuticals and active pharmaceutical ingredient (API) consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients..

Additionally, here are a few investment firms who have increased or decreased their stake in (MNK). Farmers & Merchants Investments Inc downsized its ownership by selling 14 shares a decrease of 46.7% in the quarter. Farmers & Merchants Investments Inc now holds 16 shares with a value of $1,000. The total value of its holdings decreased 0.0%. Denali Advisors LLC augmented its investment by buying 13,000 shares an increase of 520.0% as of 09/30/2017. Denali Advisors LLC claims 15,500 shares valued at $579,000. The value of the position overall is up by 417.0%.

As of the end of the quarter State Treasurer State Of Michigan had bought 3,888 shares growing its position 11.9%. The value of the company’s investment in Mallinckrodt plc Ordinary Share went from $1,461,000 to $1,364,000 a change of $97,000 since the last quarter. Robeco Institutional Asset Management B.v. added to its position by buying 17,835 shares an increase of 4.0%. Robeco Institutional Asset Management B.v. now controls 459,460 shares worth $17,173,000. The value of the position overall is down by 13.2%.

On October 4 the company was set at “Hold” in a report from Canaccord Genuity a cut from the previous “Hold” rating. August 25 investment analysts at Jefferies kept the company rating at “Buy” and moved down the price target to $60.00 from $140.00.

On August 9 Deutsche Bank held the company rating at “Buy” and lowered the price expectation from $73.00 to $56.00.

In the last earnings report the EPS was $-4.63 and is projected to be $7.38 for the current year with 97,178,000 shares presently outstanding. Next quarter’s EPS is forecasted to be $2.04 and the next full year EPS is anticipated to be $8.04.